Atreca Announces Appointment of Dr. Lindsey Rolfe to its Board of Directors

REDWOOD CITY, Calif., Aug. 26, 2019 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics based on a deep understanding of the human immune response, today announced the?appointment of Lindsey Rolfe, BSc, MB ChB, MRCP, FFPM, to the company?s Board of Directors. In addition, Lawrence Steinman, M.D., Stanford University Professor and co-founder of Atreca,?has resigned?from the Board, effective as of August 22, 2019, but will continue to serve as a technical advisor to the company.

Click to view original post